Northrop Grumman is trading 5.6% down at $494.55 in pre-market action following the release of its second-quarter 2026 financial results.
- The company beat analyst expectations for both revenue and GAAP EPS and raised its full-year 2026 sales and earnings guidance.
- Despite the headline beats, the stock's decline follows a strong recent run, suggesting profit-taking and investor scrutiny of specific segment performance and outlook details.